A detailed history of Prudential Financial Inc transactions in Exelixis, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 19,682 shares of EXEL stock, worth $689,854. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,682
Previous 91,594 78.51%
Holding current value
$689,854
Previous $2.06 Million 75.22%
% of portfolio
0.0%
Previous 0.0%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$21.96 - $27.6 $1.58 Million - $1.98 Million
-71,912 Reduced 78.51%
19,682 $510,000
Q2 2024

Aug 13, 2024

SELL
$20.34 - $23.73 $3.92 Million - $4.57 Million
-192,519 Reduced 67.76%
91,594 $2.06 Million
Q1 2024

May 14, 2024

SELL
$20.17 - $23.93 $11.8 Million - $14 Million
-586,773 Reduced 67.38%
284,113 $6.74 Million
Q4 2023

Feb 13, 2024

BUY
$19.25 - $24.13 $13 Million - $16.3 Million
673,483 Added 341.17%
870,886 $20.9 Million
Q3 2023

Nov 13, 2023

BUY
$19.04 - $22.74 $3.37 Million - $4.02 Million
176,988 Added 866.95%
197,403 $4.31 Million
Q2 2023

Aug 11, 2023

SELL
$18.17 - $20.48 $22,203 - $25,026
-1,222 Reduced 5.65%
20,415 $390,000
Q1 2023

May 12, 2023

SELL
$16.3 - $19.41 $4.54 Million - $5.41 Million
-278,531 Reduced 92.79%
21,637 $419,000
Q4 2022

Feb 14, 2023

SELL
$14.96 - $17.39 $1.24 Million - $1.44 Million
-82,573 Reduced 21.57%
300,168 $0
Q3 2022

Nov 04, 2022

SELL
$15.68 - $22.27 $33.2 Million - $47.1 Million
-2,115,636 Reduced 84.68%
382,741 $6.06 Million
Q2 2022

Aug 15, 2022

BUY
$17.44 - $23.16 $34.3 Million - $45.5 Million
1,965,534 Added 368.88%
2,498,377 $52 Million
Q1 2022

May 13, 2022

BUY
$17.03 - $22.67 $3.17 Million - $4.22 Million
186,323 Added 53.77%
532,843 $12.1 Million
Q4 2021

Feb 14, 2022

SELL
$15.84 - $21.88 $5.59 Million - $7.72 Million
-352,727 Reduced 50.44%
346,520 $6.56 Million
Q3 2021

Nov 15, 2021

BUY
$16.3 - $21.14 $10.3 Million - $13.4 Million
632,270 Added 944.01%
699,247 $14.5 Million
Q2 2021

Aug 16, 2021

BUY
$17.95 - $25.56 $399,620 - $569,042
22,263 Added 49.79%
66,977 $1.22 Million
Q1 2021

May 12, 2021

SELL
$20.53 - $25.22 $2.96 Million - $3.63 Million
-144,080 Reduced 76.32%
44,714 $1.01 Million
Q4 2020

Feb 16, 2021

BUY
$18.39 - $24.8 $3.47 Million - $4.68 Million
188,580 Added 88121.5%
188,794 $3.79 Million
Q3 2020

Aug 05, 2021

SELL
$20.67 - $26.94 $10.1 Million - $13.2 Million
-490,293 Reduced 99.96%
214 $5,000
Q3 2020

Nov 16, 2020

BUY
$20.67 - $26.94 $10.1 Million - $13.2 Million
490,320 Added 262203.22%
490,507 $12 Million
Q2 2020

Aug 05, 2021

SELL
$16.46 - $27.42 $17.6 Million - $29.3 Million
-1,067,605 Reduced 99.98%
187 $4,000
Q2 2020

Aug 12, 2020

BUY
$16.46 - $27.42 $17.6 Million - $29.3 Million
1,067,451 Added 313035.47%
1,067,792 $25.3 Million
Q1 2020

Aug 05, 2021

SELL
$14.46 - $21.8 $7.03 Million - $10.6 Million
-486,051 Reduced 99.93%
341 $6,000
Q1 2020

May 12, 2020

BUY
$14.46 - $21.8 $7.03 Million - $10.6 Million
486,117 Added 176769.81%
486,392 $8.38 Million
Q4 2019

Aug 05, 2021

SELL
$15.15 - $18.89 $28.2 Million - $35.1 Million
-1,859,857 Reduced 99.99%
275 $5,000
Q4 2019

Feb 11, 2020

BUY
$15.15 - $18.89 $28.2 Million - $35.1 Million
1,859,978 Added 1207777.88%
1,860,132 $32.8 Million
Q3 2019

Aug 05, 2021

SELL
$17.68 - $22.65 $37.5 Million - $48 Million
-2,119,738 Reduced 99.99%
154 $3,000
Q3 2019

Nov 13, 2019

BUY
$17.68 - $22.65 $37.5 Million - $48 Million
2,119,712 Added 1177617.75%
2,119,892 $37.5 Million
Q2 2019

Aug 05, 2021

SELL
$18.93 - $24.75 $32.4 Million - $42.3 Million
-1,709,777 Reduced 99.99%
180 $4,000
Q2 2019

Aug 08, 2019

BUY
$18.93 - $24.75 $32.2 Million - $42 Million
1,698,895 Added 15357.94%
1,709,957 $0
Q1 2019

Aug 05, 2021

SELL
$19.6 - $24.76 $16.5 Million - $20.8 Million
-840,305 Reduced 98.7%
11,062 $263,000
Q1 2019

May 15, 2019

SELL
$19.6 - $24.76 $14.6 Million - $18.5 Million
-746,800 Reduced 46.73%
851,367 $0
Q4 2018

Feb 07, 2019

BUY
$13.65 - $21.8 $17.9 Million - $28.5 Million
1,308,617 Added 451.95%
1,598,167 $31.4 Million
Q3 2018

Nov 07, 2018

SELL
$15.87 - $22.4 $1.78 Million - $2.51 Million
-111,980 Reduced 27.89%
289,550 $0
Q2 2018

Aug 13, 2018

SELL
$18.56 - $22.45 $558,656 - $675,745
-30,100 Reduced 6.97%
401,530 $0
Q1 2018

May 04, 2018

SELL
$22.15 - $31.89 $945,804 - $1.36 Million
-42,700 Reduced 9.0%
431,630 $0
Q4 2017

Feb 13, 2018

BUY
$24.23 - $30.93 $1.75 Million - $2.23 Million
72,100 Added 17.93%
474,330 $14.4 Million
Q3 2017

Nov 02, 2017

BUY
$23.35 - $29.24 $9.39 Million - $11.8 Million
402,230
402,230 $9.75 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.3B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.